Platelet Aggregation Devices Market by Product (Systems, Reagents, Consumables, Accessories), Application (Research, Diagnostic, CVD, Orthopedic, Trauma), End User (Hospitals, Diagnostic Laboratories, Academia, Blood Banks) - Global Forecasts to 2020
The global platelet aggregation devices market is poised to grow at a CAGR of 21.0% during the forecast period (2015-2020), and is expected to reach a value of ~$342.4 million by 2020. Mature markets (such as the U.S., Germany, France, and the U.K.) hold large shares in the global platelet aggregation devices market, and the North American region (particularly the U.S.) is expected to grow at the highest CAGR in the forecast period. Overall growth in the global platelet aggregation devices market is driven by the rising incidences of target diseases, rapid growth in the geriatric population across the globe, technological advancements in platelet aggregometers, and increasing number of industry-academia collaborations and clinical studies. However, factors such as procedural limitations, unfavorable healthcare reforms in the U.S., and dearth of well trained and skilled professionals are restraining the growth of this market. In addition, stringent regulatory policies and limited medical reimbursements are posing significant challenges for the growth of the platelet aggregation devices market.
In this report, the global platelet aggregation devices market is segmented on the basis of products (systems, reagents, and consumables and accessories), applications (research applications and clinical applications), and end users (standalone hospitals, diagnostic laboratories, research and academic institutes, and other end users). The systems segment is expected to account for the largest share of the global platelet aggregation products market in 2015, followed by the reagents segment. Factors such as continuous technological advancements in the field of sensors and detectors, rising trend of automation of platelet aggregation testing procedures, growing adoption and market preference for automated instruments among diagnostic laboratories, and improved patient compliance offered by point-of-care testing analyzers as compared to conventional instruments are driving the growth of the platelet aggregation systems market.
Geographically, North America (comprising the U.S. and Canada) is expected to command the largest share of the global platelet aggregation devices market in 2015, followed by Europe. North America is also poised to grow at the highest CAGR during the forecast period, owing to factors such as large patient population for target diseases, strong presence of device manufacturers, growing number of surgical procedures, rising awareness among healthcare professionals (related to the benefits offered by platelet aggregation testing in disease diagnosis), large number of patients undergoing cardiovascular surgeries, and increasing prevalence of orthopedic, urological, and bleeding disorders. The global platelet aggregation devices market is moderately competitive with the presence of various global as well as local players. As of 2014, the global platelet aggregation devices market was dominated by F. Hoffmann La-Roche Ltd. (Switzerland), Haemonetics Corporation (U.S.), Sysmex Corporation (Japan), Siemens AG (Germany), and Accriva Diagnostics (U.S.), that together accounted for ~85.0% of the market. New product launches; partnerships, agreements, and collaborations; and strategic acquisitions and divestments are the major strategies adopted by most of the market players to achieve growth in the global platelet aggregation devices market.
Reasons to Buy the Report:
From an insight perspective, this research report has focused on various levels of analysis such as market share analysis of top ten players and company profiles, which together comprise and discuss the basic views on the competitive landscape, emerging and high-growth segments of the platelet aggregation devices market, and high-growth regions and their respective drivers, restraints, challenges, and opportunities.
The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn helps firms garner higher market shares. Firms purchasing the report could use any one or a combination of the below-mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market shares.
The report provides insights on the following pointers:
In this report, the global platelet aggregation devices market is segmented on the basis of products (systems, reagents, and consumables and accessories), applications (research applications and clinical applications), and end users (standalone hospitals, diagnostic laboratories, research and academic institutes, and other end users). The systems segment is expected to account for the largest share of the global platelet aggregation products market in 2015, followed by the reagents segment. Factors such as continuous technological advancements in the field of sensors and detectors, rising trend of automation of platelet aggregation testing procedures, growing adoption and market preference for automated instruments among diagnostic laboratories, and improved patient compliance offered by point-of-care testing analyzers as compared to conventional instruments are driving the growth of the platelet aggregation systems market.
Geographically, North America (comprising the U.S. and Canada) is expected to command the largest share of the global platelet aggregation devices market in 2015, followed by Europe. North America is also poised to grow at the highest CAGR during the forecast period, owing to factors such as large patient population for target diseases, strong presence of device manufacturers, growing number of surgical procedures, rising awareness among healthcare professionals (related to the benefits offered by platelet aggregation testing in disease diagnosis), large number of patients undergoing cardiovascular surgeries, and increasing prevalence of orthopedic, urological, and bleeding disorders. The global platelet aggregation devices market is moderately competitive with the presence of various global as well as local players. As of 2014, the global platelet aggregation devices market was dominated by F. Hoffmann La-Roche Ltd. (Switzerland), Haemonetics Corporation (U.S.), Sysmex Corporation (Japan), Siemens AG (Germany), and Accriva Diagnostics (U.S.), that together accounted for ~85.0% of the market. New product launches; partnerships, agreements, and collaborations; and strategic acquisitions and divestments are the major strategies adopted by most of the market players to achieve growth in the global platelet aggregation devices market.
Reasons to Buy the Report:
From an insight perspective, this research report has focused on various levels of analysis such as market share analysis of top ten players and company profiles, which together comprise and discuss the basic views on the competitive landscape, emerging and high-growth segments of the platelet aggregation devices market, and high-growth regions and their respective drivers, restraints, challenges, and opportunities.
The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn helps firms garner higher market shares. Firms purchasing the report could use any one or a combination of the below-mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market shares.
The report provides insights on the following pointers:
- Market Penetration: Comprehensive information on platelet aggregation products offered by the top 10 players in the global platelet aggregation devices market. The report analyzes the platelet aggregation devices market by product, application, and end user across key geographic regions
- Product Development/Innovation: Detailed insights on upcoming platelet aggregation testing technologies, research and development activities, and new product launches in the global platelet aggregation devices market
- Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various platelet aggregation products across key geographic regions
- Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the global platelet aggregation devices market
- Competitive Assessment: In-depth assessment of market shares, strategies, products, distribution networks, and manufacturing capabilities of the leading players in the global platelet aggregation devices market
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED
1.3.2 GEOGRAPHIC SCOPE
1.3.3 YEARS CONSIDERED FOR THE STUDY
1.4 CURRENCY
1.5 LIMITATIONS
1.6 STAKEHOLDERS
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
2.1.1 SECONDARY DATA
2.1.1.1 Key data from secondary sources
2.1.2 PRIMARY DATA
2.1.2.1 Key data from primary sources
2.1.2.2 Breakdown of primaries
2.2 MARKET SIZE ESTIMATION
2.2.1 BOTTOM-UP APPROACH
2.2.2 TOP-DOWN APPROACH
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
2.4 RESEARCH ASSUMPTIONS
2.4.1 ASSUMPTIONS
3 EXECUTIVE SUMMARY
3.1 INTRODUCTION
3.2 CURRENT MARKET SCENARIO
3.3 FUTURE OUTLOOK
3.4 CONCLUSION
4 PREMIUM INSIGHTS
4.1 GLOBAL PLATELET AGGREGATION DEVICES MARKET, 2015–2020
4.2 GLOBAL PLATELET AGGREGATION DEVICES MARKET, BY REGION (2015–2020)
4.3 PLATELET AGGREGATION DEVICES MARKET, BY PRODUCT (2015)
4.4 GLOBAL PLATELET AGGREGATION DEVICES MARKET, BY APPLICATION (2015–2020)
4.5 GLOBAL PLATELET AGGREGATION DEVICES MARKET, BY END USER (2015–2020)
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET SEGMENTATION
5.3 MARKET DYNAMICS
5.3.1 KEY MARKET DRIVERS
5.3.1.1 Rising incidence of target diseases
5.3.1.2 Rapid growth in the geriatric population across the globe
5.3.1.3 Technological advancements in platelet aggregometers
5.3.1.4 Increasing number of industry-academia collaborations and clinical studies
5.3.2 KEY MARKET RESTRAINTS
5.3.2.1 Procedural limitations
5.3.2.2 Unfavorable healthcare reforms in the U.S.
5.3.2.3 Dearth of well-trained, skilled, and experienced professionals
5.3.3 KEY MARKET OPPORTUNITIES
5.3.3.1 Emerging markets
5.3.3.2 Advent of point-of-care & miniaturized platelet aggregometers
5.3.4 KEY MARKET CHALLENGES
5.3.4.1 Stringent regulatory policies
5.3.4.2 Limited medical reimbursements
6 PLATELET AGGREGATION DEVICES MARKET, BY PRODUCT
6.1 INTRODUCTION
6.2 SYSTEMS
6.3 REAGENTS
6.4 CONSUMABLES AND ACCESSORIES
7 PLATELET AGGREGATION DEVICES MARKET, BY APPLICATION
7.1 INTRODUCTION
7.2 CLINICAL APPLICATIONS
7.2.1 CARDIOVASCULAR APPLICATIONS
7.2.2 ORTHOPEDIC APPLICATIONS
7.2.3 OTHER CLINICAL APPLICATIONS
7.3 RESEARCH APPLICATIONS
8 PLATELET AGGREGATION DEVICES MARKET, BY END USER
8.1 INTRODUCTION
8.2 STANDALONE HOSPITALS
8.3 DIAGNOSTIC LABORATORIES
8.4 RESEARCH AND ACADEMIC INSTITUTES
8.5 OTHER END USERS
9 PLATELET AGGREGATION DEVICES MARKET, BY REGION
9.1 INTRODUCTION
9.2 NORTH AMERICA
9.2.1 U.S.
9.2.2 CANADA
9.3 EUROPE
9.3.1 GERMANY
9.3.2 U.K.
9.3.3 FRANCE
9.3.4 REST OF EUROPE (ROE)
9.4 ASIA-PACIFIC
9.4.1 JAPAN
9.4.2 CHINA
9.4.3 INDIA
9.4.4 REST OF ASIA-PACIFIC (ROAPAC)
9.5 REST OF THE WORLD (ROW)
10 COMPETITIVE LANDSCAPE
10.1 OVERVIEW
10.2 MARKET SHARE ANALYSIS
10.3 COMPETITIVE SCENARIO
10.4 RECENT DEVELOPMENTS
10.4.1 NEW PRODUCT LAUNCHES AND PRODUCT ENHANCEMENTS
10.4.2 ACQUISITIONS AND DIVESTMENTS
10.4.3 AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS
10.4.4 GEOGRAPHICAL EXPANSIONS
10.4.5 OTHER DEVELOPMENTS
11 COMPANY PROFILES
(Overview, Financials, Products & Services, Strategy, & Developments)*
11.1 INTRODUCTION
11.1.1 GEOGRAPHIC REVENUE MIX
11.1.2 STRATEGIC BENCHMARKING
11.1.2.1 Product development and commercialization
11.2 F. HOFFMAN-LA ROCHE LTD.
11.3 HAEMONETICS CORPORATION
11.4 SYSMEX CORPORATION
11.5 SIEMENS AG
11.6 ACCRIVA DIAGNOSTICS
11.7 HELENA LABORATORIES CORPORATION
11.8 BIO/DATA CORPORATION
11.9 SENTINEL CH. S.P.A.
11.10 TEM GROUP
11.11 AGGREDYNE, INC.
*Details on Financials, Product & Services, Strategy, & Developments might not be captured in case of unlisted companies.
12 APPENDIX
12.1 INSIGHTS OF INDUSTRY EXPERTS
12.2 DISCUSSION GUIDE
12.3 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
12.4 AVAILABLE CUSTOMIZATIONS
12.5 RELATED REPORTS
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED
1.3.2 GEOGRAPHIC SCOPE
1.3.3 YEARS CONSIDERED FOR THE STUDY
1.4 CURRENCY
1.5 LIMITATIONS
1.6 STAKEHOLDERS
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
2.1.1 SECONDARY DATA
2.1.1.1 Key data from secondary sources
2.1.2 PRIMARY DATA
2.1.2.1 Key data from primary sources
2.1.2.2 Breakdown of primaries
2.2 MARKET SIZE ESTIMATION
2.2.1 BOTTOM-UP APPROACH
2.2.2 TOP-DOWN APPROACH
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
2.4 RESEARCH ASSUMPTIONS
2.4.1 ASSUMPTIONS
3 EXECUTIVE SUMMARY
3.1 INTRODUCTION
3.2 CURRENT MARKET SCENARIO
3.3 FUTURE OUTLOOK
3.4 CONCLUSION
4 PREMIUM INSIGHTS
4.1 GLOBAL PLATELET AGGREGATION DEVICES MARKET, 2015–2020
4.2 GLOBAL PLATELET AGGREGATION DEVICES MARKET, BY REGION (2015–2020)
4.3 PLATELET AGGREGATION DEVICES MARKET, BY PRODUCT (2015)
4.4 GLOBAL PLATELET AGGREGATION DEVICES MARKET, BY APPLICATION (2015–2020)
4.5 GLOBAL PLATELET AGGREGATION DEVICES MARKET, BY END USER (2015–2020)
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET SEGMENTATION
5.3 MARKET DYNAMICS
5.3.1 KEY MARKET DRIVERS
5.3.1.1 Rising incidence of target diseases
5.3.1.2 Rapid growth in the geriatric population across the globe
5.3.1.3 Technological advancements in platelet aggregometers
5.3.1.4 Increasing number of industry-academia collaborations and clinical studies
5.3.2 KEY MARKET RESTRAINTS
5.3.2.1 Procedural limitations
5.3.2.2 Unfavorable healthcare reforms in the U.S.
5.3.2.3 Dearth of well-trained, skilled, and experienced professionals
5.3.3 KEY MARKET OPPORTUNITIES
5.3.3.1 Emerging markets
5.3.3.2 Advent of point-of-care & miniaturized platelet aggregometers
5.3.4 KEY MARKET CHALLENGES
5.3.4.1 Stringent regulatory policies
5.3.4.2 Limited medical reimbursements
6 PLATELET AGGREGATION DEVICES MARKET, BY PRODUCT
6.1 INTRODUCTION
6.2 SYSTEMS
6.3 REAGENTS
6.4 CONSUMABLES AND ACCESSORIES
7 PLATELET AGGREGATION DEVICES MARKET, BY APPLICATION
7.1 INTRODUCTION
7.2 CLINICAL APPLICATIONS
7.2.1 CARDIOVASCULAR APPLICATIONS
7.2.2 ORTHOPEDIC APPLICATIONS
7.2.3 OTHER CLINICAL APPLICATIONS
7.3 RESEARCH APPLICATIONS
8 PLATELET AGGREGATION DEVICES MARKET, BY END USER
8.1 INTRODUCTION
8.2 STANDALONE HOSPITALS
8.3 DIAGNOSTIC LABORATORIES
8.4 RESEARCH AND ACADEMIC INSTITUTES
8.5 OTHER END USERS
9 PLATELET AGGREGATION DEVICES MARKET, BY REGION
9.1 INTRODUCTION
9.2 NORTH AMERICA
9.2.1 U.S.
9.2.2 CANADA
9.3 EUROPE
9.3.1 GERMANY
9.3.2 U.K.
9.3.3 FRANCE
9.3.4 REST OF EUROPE (ROE)
9.4 ASIA-PACIFIC
9.4.1 JAPAN
9.4.2 CHINA
9.4.3 INDIA
9.4.4 REST OF ASIA-PACIFIC (ROAPAC)
9.5 REST OF THE WORLD (ROW)
10 COMPETITIVE LANDSCAPE
10.1 OVERVIEW
10.2 MARKET SHARE ANALYSIS
10.3 COMPETITIVE SCENARIO
10.4 RECENT DEVELOPMENTS
10.4.1 NEW PRODUCT LAUNCHES AND PRODUCT ENHANCEMENTS
10.4.2 ACQUISITIONS AND DIVESTMENTS
10.4.3 AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS
10.4.4 GEOGRAPHICAL EXPANSIONS
10.4.5 OTHER DEVELOPMENTS
11 COMPANY PROFILES
(Overview, Financials, Products & Services, Strategy, & Developments)*
11.1 INTRODUCTION
11.1.1 GEOGRAPHIC REVENUE MIX
11.1.2 STRATEGIC BENCHMARKING
11.1.2.1 Product development and commercialization
11.2 F. HOFFMAN-LA ROCHE LTD.
11.3 HAEMONETICS CORPORATION
11.4 SYSMEX CORPORATION
11.5 SIEMENS AG
11.6 ACCRIVA DIAGNOSTICS
11.7 HELENA LABORATORIES CORPORATION
11.8 BIO/DATA CORPORATION
11.9 SENTINEL CH. S.P.A.
11.10 TEM GROUP
11.11 AGGREDYNE, INC.
*Details on Financials, Product & Services, Strategy, & Developments might not be captured in case of unlisted companies.
12 APPENDIX
12.1 INSIGHTS OF INDUSTRY EXPERTS
12.2 DISCUSSION GUIDE
12.3 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
12.4 AVAILABLE CUSTOMIZATIONS
12.5 RELATED REPORTS
LIST OF TABLES
Table 1 RISE IN TARGET PATIENT POPULATION IS REPLICATING INTO HIGHER MARKET DEMAND FOR PLATELET AGGREGATION PRODUCTS
Table 2 PROCEDURAL LIMITATIONS RELATED TO PLATELET AGGREGOMETRY IS RESULTING IN ITS SUBDUED ADOPTION AMONG HEALTHCARE PROFESSIONALS
Table 3 EMERGING MARKETS OFFERS SIGNIFICANT GROWTH OPPORTUNITIES IN PLATELET AGGREGATION DEVICES MARKET
Table 4 STRINGENT REGULATORY FRAMEWORK IS NEGATIVELY AFFECTING THE MARKET GROWTH IN THE U.S.
Table 5 GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY PRODUCT, 2013–2020 (USD MILLION)
Table 6 PLATELET AGGREGATION SYSTEMS MARKET SIZE, BY REGION, 2013–2020 (USD MILLION)
Table 7 PLATELET AGGREGATION REAGENTS MARKET SIZE, BY REGION, 2013–2020 (USD MILLION)
Table 8 PLATELET AGGREGATION CONSUMABLES AND ACCESSORIES MARKET SIZE, BY REGION, 2013–2020 (USD MILLION)
Table 9 GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY APPLICATION, 2013–2020 (USD MILLION)
Table 10 GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE FOR CLINICAL APPLICATIONS, BY TYPE, 2013–2020 (USD MILLION)
Table 11 PLATELET AGGREGATION DEVICES MARKET SIZE FOR CLINICAL APPLICATIONS, BY REGION, 2013–2020 (USD MILLION)
Table 12 PLATELET AGGREGATION DEVICES MARKET SIZE FOR CARDIOVASCULAR APPLICATIONS, BY REGION, 2013–2020 (USD MILLION)
Table 13 PLATELET AGGREGATION DEVICES MARKET SIZE FOR ORTHOPEDIC APPLICATIONS, BY REGION, 2013–2020 (USD MILLION)
Table 14 PLATELET AGGREGATION DEVICES MARKET SIZE FOR OTHER CLINICAL APPLICATIONS, BY REGION, 2013–2020 (USD MILLION)
Table 15 PLATELET AGGREGATION DEVICES MARKET SIZE FOR RESEARCH APPLICATIONS, BY REGION, 2013–2020 (USD MILLION)
Table 16 GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY END USER, 2013–2020 (USD MILLION)
Table 17 PLATELET AGGREGATION DEVICES MARKET SIZE FOR STANDALONE HOSPITALS, BY REGION, 2013-2020 (USD MILLION)
Table 18 PLATELET AGGREGATION DEVICES MARKET SIZE FOR DIAGNOSTIC LABORATORIES, BY REGION, 2013–2020 (USD MILLION)
Table 19 PLATELET AGGREGATION DEVICES MARKET SIZE FOR RESEARCH AND ACADEMIC INSTITUTES, BY REGION, 2013–2020 (USD MILLION)
Table 20 PLATELET AGGREGATION DEVICES MARKET SIZE FOR OTHER END USERS, BY REGION, 2013–2020 (USD MILLION)
Table 21 PLATELET AGGREGATION DEVICES MARKET SIZE, BY REGION, 2013–2020 (USD MILLION)
Table 22 NORTH AMERICA: PLATELET AGGREGATION DEVICES MARKET SIZE, BY COUNTRY, 2013–2020 (USD MILLION)
Table 23 NORTH AMERICA: PLATELET AGGREGATION DEVICES MARKET SIZE, BY PRODUCT, 2013–2020 (USD MILLION)
Table 24 NORTH AMERICA: PLATELET AGGREGATION DEVICES MARKET SIZE, BY APPLICATION, 2013–2020 (USD MILLION)
Table 25 NORTH AMERICA: PLATELET AGGREGATION DEVICES MARKET SIZE, BY END USER, 2013–2020 (USD MILLION)
Table 26 U.S.: PLATELET AGGREGATION DEVICES MARKET SIZE, BY PRODUCT, 2013–2020 (USD MILLION)
Table 27 U.S.: PLATELET AGGREGATION DEVICES MARKET SIZE, BY APPLICATION, 2013–2020 (USD MILLION)
Table 28 U.S.: PLATELET AGGREGATION DEVICES MARKET SIZE, BY END USER, 2013–2020 (USD MILLION)
Table 29 CANADA: PLATELET AGGREGATION DEVICES MARKET SIZE, BY PRODUCT, 2013–2020 (USD MILLION)
Table 30 CANADA: PLATELET AGGREGATION DEVICES MARKET SIZE, BY APPLICATION, 2013–2020 (USD MILLION)
Table 31 CANADA: PLATELET AGGREGATION DEVICES MARKET SIZE, BY END USER, 2013–2020 (USD MILLION)
Table 32 EUROPE: PLATELET AGGREGATION DEVICES MARKET SIZE, BY COUNTRY, 2013–2020 (USD MILLION)
Table 33 EUROPE: PLATELET AGGREGATION DEVICES MARKET SIZE, BY PRODUCT, 2013–2020 (USD MILLION)
Table 34 EUROPE: PLATELET AGGREGATION DEVICES MARKET SIZE, BY APPLICATION, 2013–2020 (USD MILLION)
Table 35 EUROPE: PLATELET AGGREGATION DEVICES MARKET SIZE, BY END USER, 2013–2020 (USD MILLION)
Table 36 GERMANY: PLATELET AGGREGATION DEVICES MARKET SIZE, BY PRODUCT, 2013–2020 (USD MILLION)
Table 37 GERMANY: PLATELET AGGREGATION DEVICES MARKET SIZE, BY APPLICATION, 2013–2020 (USD MILLION)
Table 38 GERMANY: PLATELET AGGREGATION DEVICES MARKET SIZE, BY END USER, 2013–2020 (USD MILLION)
Table 39 U.K.: PLATELET AGGREGATION DEVICES MARKET SIZE, BY PRODUCT, 2013–2020 (USD MILLION)
Table 40 U.K.: PLATELET AGGREGATION DEVICES MARKET SIZE, BY APPLICATION, 2013–2020 (USD MILLION)
Table 41 U.K.: PLATELET AGGREGATION DEVICES MARKET SIZE, BY END USER, 2013–2020 (USD MILLION)
Table 42 FRANCE: PLATELET AGGREGATION DEVICES MARKET SIZE, BY PRODUCT, 2013–2020 (USD MILLION)
Table 43 FRANCE: PLATELET AGGREGATION DEVICES MARKET SIZE, BY APPLICATION, 2013–2020 (USD MILLION)
Table 44 FRANCE: PLATELET AGGREGATION DEVICES MARKET SIZE, BY END USER, 2013–2020 (USD MILLION)
Table 45 ROE: PLATELET AGGREGATION DEVICES MARKET SIZE, BY PRODUCT, 2013–2020 (USD MILLION)
Table 46 ROE: PLATELET AGGREGATION DEVICES MARKET SIZE, BY APPLICATION, 2013–2020 (USD MILLION)
Table 47 ROE: PLATELET AGGREGATION DEVICES MARKET SIZE, BY END USER, 2013–2020 (USD MILLION)
Table 48 ASIA-PACIFIC: PLATELET AGGREGATION DEVICES MARKET SIZE, BY COUNTRY, 2013–2020 (USD MILLION)
Table 49 ASIA-PACIFIC: PLATELET AGGREGATION DEVICES MARKET SIZE, BY PRODUCT, 2013–2020 (USD MILLION)
Table 50 ASIA-PACIFIC: PLATELET AGGREGATION DEVICES MARKET SIZE, BY APPLICATION, 2013–2020 (USD MILLION)
Table 51 ASIA-PACIFIC: PLATELET AGGREGATION DEVICES MARKET SIZE, BY END USER, 2013–2020 (USD MILLION)
Table 52 JAPAN: PLATELET AGGREGATION DEVICES MARKET SIZE, BY PRODUCT, 2013–2020 (USD MILLION)
Table 53 JAPAN: PLATELET AGGREGATION DEVICES MARKET SIZE, BY APPLICATION, 2013–2020 (USD MILLION)
Table 54 JAPAN: PLATELET AGGREGATION DEVICES MARKET SIZE, BY END USER, 2013–2020 (USD MILLION)
Table 55 CHINA: PLATELET AGGREGATION DEVICES MARKET SIZE, BY PRODUCT, 2013–2020 (USD MILLION)
Table 56 CHINA: PLATELET AGGREGATION DEVICES MARKET SIZE, BY APPLICATION, 2013–2020 (USD MILLION)
Table 57 CHINA: PLATELET AGGREGATION DEVICES MARKET SIZE, BY END USER, 2013–2020 (USD MILLION)
Table 58 INDIA: PLATELET AGGREGATION DEVICES MARKET SIZE, BY PRODUCT, 2013–2020 (USD MILLION)
Table 59 INDIA: PLATELET AGGREGATION DEVICES MARKET SIZE, BY APPLICATION, 2013–2020 (USD MILLION)
Table 60 INDIA: PLATELET AGGREGATION DEVICES MARKET SIZE, BY END USER, 2013–2020 (USD MILLION)
Table 61 ROAPAC: PLATELET AGGREGATION DEVICES MARKET SIZE, BY PRODUCT, 2013–2020 (USD MILLION)
Table 62 ROAPAC: PLATELET AGGREGATION DEVICES MARKET SIZE, BY APPLICATION, 2013–2020 (USD MILLION)
Table 63 ROAPAC: PLATELET AGGREGATION DEVICES MARKET SIZE, BY END USER, 2013–2020 (USD MILLION)
Table 64 ROW: PLATELET AGGREGATION DEVICES MARKET SIZE, BY PRODUCT, 2013–2020 (USD MILLION)
Table 65 ROW: PLATELET AGGREGATION DEVICES MARKET SIZE, BY APPLICATION, 2013–2020 (USD MILLION)
Table 66 ROW: PLATELET AGGREGATION DEVICES MARKET SIZE, BY END USER, 2013–2020 (USD MILLION)
Table 67 NEW PRODUCT LAUNCHES AND PRODUCT ENHANCEMENTS, 2012–2015
Table 68 ACQUISITIONS AND DIVESTMENTS, 2012–2015
Table 69 AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS, 2012–2015
Table 70 GEOGRAPHICAL EXPANSIONS, 2012–2015
Table 71 OTHER DEVELOPMENTS, 2012–2015
Table 1 RISE IN TARGET PATIENT POPULATION IS REPLICATING INTO HIGHER MARKET DEMAND FOR PLATELET AGGREGATION PRODUCTS
Table 2 PROCEDURAL LIMITATIONS RELATED TO PLATELET AGGREGOMETRY IS RESULTING IN ITS SUBDUED ADOPTION AMONG HEALTHCARE PROFESSIONALS
Table 3 EMERGING MARKETS OFFERS SIGNIFICANT GROWTH OPPORTUNITIES IN PLATELET AGGREGATION DEVICES MARKET
Table 4 STRINGENT REGULATORY FRAMEWORK IS NEGATIVELY AFFECTING THE MARKET GROWTH IN THE U.S.
Table 5 GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY PRODUCT, 2013–2020 (USD MILLION)
Table 6 PLATELET AGGREGATION SYSTEMS MARKET SIZE, BY REGION, 2013–2020 (USD MILLION)
Table 7 PLATELET AGGREGATION REAGENTS MARKET SIZE, BY REGION, 2013–2020 (USD MILLION)
Table 8 PLATELET AGGREGATION CONSUMABLES AND ACCESSORIES MARKET SIZE, BY REGION, 2013–2020 (USD MILLION)
Table 9 GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY APPLICATION, 2013–2020 (USD MILLION)
Table 10 GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE FOR CLINICAL APPLICATIONS, BY TYPE, 2013–2020 (USD MILLION)
Table 11 PLATELET AGGREGATION DEVICES MARKET SIZE FOR CLINICAL APPLICATIONS, BY REGION, 2013–2020 (USD MILLION)
Table 12 PLATELET AGGREGATION DEVICES MARKET SIZE FOR CARDIOVASCULAR APPLICATIONS, BY REGION, 2013–2020 (USD MILLION)
Table 13 PLATELET AGGREGATION DEVICES MARKET SIZE FOR ORTHOPEDIC APPLICATIONS, BY REGION, 2013–2020 (USD MILLION)
Table 14 PLATELET AGGREGATION DEVICES MARKET SIZE FOR OTHER CLINICAL APPLICATIONS, BY REGION, 2013–2020 (USD MILLION)
Table 15 PLATELET AGGREGATION DEVICES MARKET SIZE FOR RESEARCH APPLICATIONS, BY REGION, 2013–2020 (USD MILLION)
Table 16 GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY END USER, 2013–2020 (USD MILLION)
Table 17 PLATELET AGGREGATION DEVICES MARKET SIZE FOR STANDALONE HOSPITALS, BY REGION, 2013-2020 (USD MILLION)
Table 18 PLATELET AGGREGATION DEVICES MARKET SIZE FOR DIAGNOSTIC LABORATORIES, BY REGION, 2013–2020 (USD MILLION)
Table 19 PLATELET AGGREGATION DEVICES MARKET SIZE FOR RESEARCH AND ACADEMIC INSTITUTES, BY REGION, 2013–2020 (USD MILLION)
Table 20 PLATELET AGGREGATION DEVICES MARKET SIZE FOR OTHER END USERS, BY REGION, 2013–2020 (USD MILLION)
Table 21 PLATELET AGGREGATION DEVICES MARKET SIZE, BY REGION, 2013–2020 (USD MILLION)
Table 22 NORTH AMERICA: PLATELET AGGREGATION DEVICES MARKET SIZE, BY COUNTRY, 2013–2020 (USD MILLION)
Table 23 NORTH AMERICA: PLATELET AGGREGATION DEVICES MARKET SIZE, BY PRODUCT, 2013–2020 (USD MILLION)
Table 24 NORTH AMERICA: PLATELET AGGREGATION DEVICES MARKET SIZE, BY APPLICATION, 2013–2020 (USD MILLION)
Table 25 NORTH AMERICA: PLATELET AGGREGATION DEVICES MARKET SIZE, BY END USER, 2013–2020 (USD MILLION)
Table 26 U.S.: PLATELET AGGREGATION DEVICES MARKET SIZE, BY PRODUCT, 2013–2020 (USD MILLION)
Table 27 U.S.: PLATELET AGGREGATION DEVICES MARKET SIZE, BY APPLICATION, 2013–2020 (USD MILLION)
Table 28 U.S.: PLATELET AGGREGATION DEVICES MARKET SIZE, BY END USER, 2013–2020 (USD MILLION)
Table 29 CANADA: PLATELET AGGREGATION DEVICES MARKET SIZE, BY PRODUCT, 2013–2020 (USD MILLION)
Table 30 CANADA: PLATELET AGGREGATION DEVICES MARKET SIZE, BY APPLICATION, 2013–2020 (USD MILLION)
Table 31 CANADA: PLATELET AGGREGATION DEVICES MARKET SIZE, BY END USER, 2013–2020 (USD MILLION)
Table 32 EUROPE: PLATELET AGGREGATION DEVICES MARKET SIZE, BY COUNTRY, 2013–2020 (USD MILLION)
Table 33 EUROPE: PLATELET AGGREGATION DEVICES MARKET SIZE, BY PRODUCT, 2013–2020 (USD MILLION)
Table 34 EUROPE: PLATELET AGGREGATION DEVICES MARKET SIZE, BY APPLICATION, 2013–2020 (USD MILLION)
Table 35 EUROPE: PLATELET AGGREGATION DEVICES MARKET SIZE, BY END USER, 2013–2020 (USD MILLION)
Table 36 GERMANY: PLATELET AGGREGATION DEVICES MARKET SIZE, BY PRODUCT, 2013–2020 (USD MILLION)
Table 37 GERMANY: PLATELET AGGREGATION DEVICES MARKET SIZE, BY APPLICATION, 2013–2020 (USD MILLION)
Table 38 GERMANY: PLATELET AGGREGATION DEVICES MARKET SIZE, BY END USER, 2013–2020 (USD MILLION)
Table 39 U.K.: PLATELET AGGREGATION DEVICES MARKET SIZE, BY PRODUCT, 2013–2020 (USD MILLION)
Table 40 U.K.: PLATELET AGGREGATION DEVICES MARKET SIZE, BY APPLICATION, 2013–2020 (USD MILLION)
Table 41 U.K.: PLATELET AGGREGATION DEVICES MARKET SIZE, BY END USER, 2013–2020 (USD MILLION)
Table 42 FRANCE: PLATELET AGGREGATION DEVICES MARKET SIZE, BY PRODUCT, 2013–2020 (USD MILLION)
Table 43 FRANCE: PLATELET AGGREGATION DEVICES MARKET SIZE, BY APPLICATION, 2013–2020 (USD MILLION)
Table 44 FRANCE: PLATELET AGGREGATION DEVICES MARKET SIZE, BY END USER, 2013–2020 (USD MILLION)
Table 45 ROE: PLATELET AGGREGATION DEVICES MARKET SIZE, BY PRODUCT, 2013–2020 (USD MILLION)
Table 46 ROE: PLATELET AGGREGATION DEVICES MARKET SIZE, BY APPLICATION, 2013–2020 (USD MILLION)
Table 47 ROE: PLATELET AGGREGATION DEVICES MARKET SIZE, BY END USER, 2013–2020 (USD MILLION)
Table 48 ASIA-PACIFIC: PLATELET AGGREGATION DEVICES MARKET SIZE, BY COUNTRY, 2013–2020 (USD MILLION)
Table 49 ASIA-PACIFIC: PLATELET AGGREGATION DEVICES MARKET SIZE, BY PRODUCT, 2013–2020 (USD MILLION)
Table 50 ASIA-PACIFIC: PLATELET AGGREGATION DEVICES MARKET SIZE, BY APPLICATION, 2013–2020 (USD MILLION)
Table 51 ASIA-PACIFIC: PLATELET AGGREGATION DEVICES MARKET SIZE, BY END USER, 2013–2020 (USD MILLION)
Table 52 JAPAN: PLATELET AGGREGATION DEVICES MARKET SIZE, BY PRODUCT, 2013–2020 (USD MILLION)
Table 53 JAPAN: PLATELET AGGREGATION DEVICES MARKET SIZE, BY APPLICATION, 2013–2020 (USD MILLION)
Table 54 JAPAN: PLATELET AGGREGATION DEVICES MARKET SIZE, BY END USER, 2013–2020 (USD MILLION)
Table 55 CHINA: PLATELET AGGREGATION DEVICES MARKET SIZE, BY PRODUCT, 2013–2020 (USD MILLION)
Table 56 CHINA: PLATELET AGGREGATION DEVICES MARKET SIZE, BY APPLICATION, 2013–2020 (USD MILLION)
Table 57 CHINA: PLATELET AGGREGATION DEVICES MARKET SIZE, BY END USER, 2013–2020 (USD MILLION)
Table 58 INDIA: PLATELET AGGREGATION DEVICES MARKET SIZE, BY PRODUCT, 2013–2020 (USD MILLION)
Table 59 INDIA: PLATELET AGGREGATION DEVICES MARKET SIZE, BY APPLICATION, 2013–2020 (USD MILLION)
Table 60 INDIA: PLATELET AGGREGATION DEVICES MARKET SIZE, BY END USER, 2013–2020 (USD MILLION)
Table 61 ROAPAC: PLATELET AGGREGATION DEVICES MARKET SIZE, BY PRODUCT, 2013–2020 (USD MILLION)
Table 62 ROAPAC: PLATELET AGGREGATION DEVICES MARKET SIZE, BY APPLICATION, 2013–2020 (USD MILLION)
Table 63 ROAPAC: PLATELET AGGREGATION DEVICES MARKET SIZE, BY END USER, 2013–2020 (USD MILLION)
Table 64 ROW: PLATELET AGGREGATION DEVICES MARKET SIZE, BY PRODUCT, 2013–2020 (USD MILLION)
Table 65 ROW: PLATELET AGGREGATION DEVICES MARKET SIZE, BY APPLICATION, 2013–2020 (USD MILLION)
Table 66 ROW: PLATELET AGGREGATION DEVICES MARKET SIZE, BY END USER, 2013–2020 (USD MILLION)
Table 67 NEW PRODUCT LAUNCHES AND PRODUCT ENHANCEMENTS, 2012–2015
Table 68 ACQUISITIONS AND DIVESTMENTS, 2012–2015
Table 69 AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS, 2012–2015
Table 70 GEOGRAPHICAL EXPANSIONS, 2012–2015
Table 71 OTHER DEVELOPMENTS, 2012–2015
LIST OF FIGURES
Figure 1 RESEARCH DESIGN
Figure 2 BOTTOM-UP APPROACH
Figure 3 TOP-DOWN APPROACH
Figure 4 DATA TRIANGULATION
Figure 5 ASSUMPTIONS OF THE RESEARCH STUDY
Figure 6 PLATELET AGGREGATION DEVICES MARKET SHARE: KEY MARKET PLAYERS, 2014
Figure 7 FUTURE TRENDS: PLATELET AGGREGATION DEVICES MARKET SIZE, BY PRODUCT TYPE (2015–2020)
Figure 8 FUTURE TRENDS: PLATELET AGGREGATION DEVICES MARKET SIZE, BY APPLICATION (2015–2020)
Figure 9 FUTURE TRENDS: PLATELET AGGREGATION DEVICES MARKET SHARE, BY REGION (2015–2020)
Figure 10 ATTRACTIVE MARKET OPPORTUNITIES IN THE PLATELET AGGREGATION DEVICES MARKET
Figure 11 CHINA, U.S., & INDIA TO LEAD THE PLATELET AGGREGATION DEVICES MARKET DURING THE FORECAST PERIOD
Figure 12 NORTH AMERICA IS EXPECTED TO COMMAND THE LARGEST SHARE OF THE PLATELET AGGREGATION PRODUCTS MARKET IN 2015
Figure 13 CHINA TO LEAD THE MARKET FOR PLATLET AGGREGATION DEVICE APPLICATIONS DURING THE FORECAST PERIOD
Figure 14 STANDALONE HOSPITALS TO BE THE KEY END-USER SEGMENT ACROSS ALL THE KEY REGIONS FOR PLATELET AGGREGATION PRODUCTS
Figure 15 KEY FACTORS IMPACTING GROWTH OF THE PLATELET AGGREGATION DEVICES MARKET DURING 2015–2020
Figure 16 INCREASING PROPORTION OF GERIATRIC INDIVIDUALS IN THE TOTAL POPULATION (2012 VS. 2020)
Figure 17 GLOBAL TREND IN THE GOVERNMENT HEALTHCARE EXPENDITURE: DEVELOPED VS DEVELOPING NATIONS (2010–2012)
Figure 18 PLATELET AGGREGATION SYSTEMS TO GROW THE FASTEST AMONG ALL PRODUCTS CATEGORIES DURING 2015 TO 2020
Figure 19 PLATELET AGGREGATION DEVICES MARKET IS EXPECTED TO WITNESS HIGHER GROWTH FOR CLINICAL APPLICATIONS SEGMENT DURING THE FORECAST PERIOD
Figure 20 GROWING GERIATRIC POPULATION IS EXPECTED TO FUEL THE MARKET DEMAND DURING THE FORECAST PERIOD
Figure 21 PLATELET AGGREGATION RESEARCH APPLICATIONS MARKET IN NORTH AMERICA IS POISED TO GROW AT THE HIGHEST CAGR DURING 2015-2020
Figure 22 STANDALONE HOSPITALS TO WITNESS HIGHEST GROWTH AMONG ALL END USERS (2015-2020)
Figure 23 RISING HEALTHCARE EXPENDITURE ACROSS THE GLOBE TO STIMULATE THE MARKET DEMAND OF PLATELET AGGREGATION TESTING PRODUCTS (2010-2012)
Figure 24 LARGE NUMBER OF ONGOING CLINICAL TRIALS IS PROPELLING THE DEMAND FOR PLATELET AGGREGATION TESTING PRODUCTS BY PHARMA & BIOTECH COMPANIES (2015)
Figure 25 NORTH AMERICA TO LEAD THE PLATELET AGGREGATION DEVICES MARKET AMONG KEY REGIONS DURING 2015–2020
Figure 26 THE NORTH AMERICAN PLATELET AGGREGATION DEVICES MARKET IS MAINLY DRIVEN BY HIGH INCIDENCES OF TARGET DISEASES IN THIS REGION
Figure 27 PLATELET AGGREGATION SYSTEMS TO CONTRIBUTE THE MAXIMUM TO THE PLATELET AGGREGATION PRODUCTS MARKET GROWTH IN THE U.S. DURING THE FORECAST PERIOD
Figure 28 EUROPEAN MARKET SNAPSHOT: GERMANY IS EXPECTED TO COMMAND THE LARGEST MARKET SHARE IN 2015
Figure 29 CLINICAL APPLICATIONS TO HOLD THE LARGER MARKET SHARE IN THE PLATELET AGGREGATION DEVICES APPLICATIONS MARKET IN THE U.K. (2015–2020)
Figure 30 ASIA-PACIFIC MARKET SNAPSHOT: CHINA IS EXPECTED TO BE THE FASTEST-GROWING REGIONAL SEGMENT IN APAC (2015–2020)
Figure 31 STANDALONE HOSPITALS SEGMENT IS PROJECTED TO BE THE FASTEST-GROWING END-USER SEGMENT IN CHINA (2015–2020)
Figure 32 LEADING MARKET PLAYERS ADOPTED PIPELINE DEVELOPMENT & PRODUCT ENHANCEMENT AS THEIR KEY GROWTH STRATEGY DURING 2012 TO 2015
Figure 33 GLOBAL PLATELET AGGREGATION DEVICES MARKET SHARE, BY KEY PLAYER, 2014
Figure 34 CONTINUOUS PRODUCT DEVELOPMENT & COMMERCIALIZATION IS STIMULATING MARKET COMPETITION AMONG KEY PLAYERS
Figure 35 GEOGRAPHIC REVENUE MIX OF THE TOP FOUR PLAYERS (2014)
Figure 36 STRATEGIC BENCHMARKING: LEADING COMPANIES FOCUS ON PRODUCT COMMERCIALIZATION TO STRENGTHEN THEIR MARKET POSITION
Figure 37 F. HOFFMAN-LA ROCHE LTD.: COMPANY SNAPSHOT
Figure 38 HAEMONETICS CORPORATION: COMPANY SNAPSHOT
Figure 39 SYSMEX CORPORATION: COMPANY SNAPSHOT
Figure 40 SIEMENS AG: COMPANY SNAPSHOT
Figure 1 RESEARCH DESIGN
Figure 2 BOTTOM-UP APPROACH
Figure 3 TOP-DOWN APPROACH
Figure 4 DATA TRIANGULATION
Figure 5 ASSUMPTIONS OF THE RESEARCH STUDY
Figure 6 PLATELET AGGREGATION DEVICES MARKET SHARE: KEY MARKET PLAYERS, 2014
Figure 7 FUTURE TRENDS: PLATELET AGGREGATION DEVICES MARKET SIZE, BY PRODUCT TYPE (2015–2020)
Figure 8 FUTURE TRENDS: PLATELET AGGREGATION DEVICES MARKET SIZE, BY APPLICATION (2015–2020)
Figure 9 FUTURE TRENDS: PLATELET AGGREGATION DEVICES MARKET SHARE, BY REGION (2015–2020)
Figure 10 ATTRACTIVE MARKET OPPORTUNITIES IN THE PLATELET AGGREGATION DEVICES MARKET
Figure 11 CHINA, U.S., & INDIA TO LEAD THE PLATELET AGGREGATION DEVICES MARKET DURING THE FORECAST PERIOD
Figure 12 NORTH AMERICA IS EXPECTED TO COMMAND THE LARGEST SHARE OF THE PLATELET AGGREGATION PRODUCTS MARKET IN 2015
Figure 13 CHINA TO LEAD THE MARKET FOR PLATLET AGGREGATION DEVICE APPLICATIONS DURING THE FORECAST PERIOD
Figure 14 STANDALONE HOSPITALS TO BE THE KEY END-USER SEGMENT ACROSS ALL THE KEY REGIONS FOR PLATELET AGGREGATION PRODUCTS
Figure 15 KEY FACTORS IMPACTING GROWTH OF THE PLATELET AGGREGATION DEVICES MARKET DURING 2015–2020
Figure 16 INCREASING PROPORTION OF GERIATRIC INDIVIDUALS IN THE TOTAL POPULATION (2012 VS. 2020)
Figure 17 GLOBAL TREND IN THE GOVERNMENT HEALTHCARE EXPENDITURE: DEVELOPED VS DEVELOPING NATIONS (2010–2012)
Figure 18 PLATELET AGGREGATION SYSTEMS TO GROW THE FASTEST AMONG ALL PRODUCTS CATEGORIES DURING 2015 TO 2020
Figure 19 PLATELET AGGREGATION DEVICES MARKET IS EXPECTED TO WITNESS HIGHER GROWTH FOR CLINICAL APPLICATIONS SEGMENT DURING THE FORECAST PERIOD
Figure 20 GROWING GERIATRIC POPULATION IS EXPECTED TO FUEL THE MARKET DEMAND DURING THE FORECAST PERIOD
Figure 21 PLATELET AGGREGATION RESEARCH APPLICATIONS MARKET IN NORTH AMERICA IS POISED TO GROW AT THE HIGHEST CAGR DURING 2015-2020
Figure 22 STANDALONE HOSPITALS TO WITNESS HIGHEST GROWTH AMONG ALL END USERS (2015-2020)
Figure 23 RISING HEALTHCARE EXPENDITURE ACROSS THE GLOBE TO STIMULATE THE MARKET DEMAND OF PLATELET AGGREGATION TESTING PRODUCTS (2010-2012)
Figure 24 LARGE NUMBER OF ONGOING CLINICAL TRIALS IS PROPELLING THE DEMAND FOR PLATELET AGGREGATION TESTING PRODUCTS BY PHARMA & BIOTECH COMPANIES (2015)
Figure 25 NORTH AMERICA TO LEAD THE PLATELET AGGREGATION DEVICES MARKET AMONG KEY REGIONS DURING 2015–2020
Figure 26 THE NORTH AMERICAN PLATELET AGGREGATION DEVICES MARKET IS MAINLY DRIVEN BY HIGH INCIDENCES OF TARGET DISEASES IN THIS REGION
Figure 27 PLATELET AGGREGATION SYSTEMS TO CONTRIBUTE THE MAXIMUM TO THE PLATELET AGGREGATION PRODUCTS MARKET GROWTH IN THE U.S. DURING THE FORECAST PERIOD
Figure 28 EUROPEAN MARKET SNAPSHOT: GERMANY IS EXPECTED TO COMMAND THE LARGEST MARKET SHARE IN 2015
Figure 29 CLINICAL APPLICATIONS TO HOLD THE LARGER MARKET SHARE IN THE PLATELET AGGREGATION DEVICES APPLICATIONS MARKET IN THE U.K. (2015–2020)
Figure 30 ASIA-PACIFIC MARKET SNAPSHOT: CHINA IS EXPECTED TO BE THE FASTEST-GROWING REGIONAL SEGMENT IN APAC (2015–2020)
Figure 31 STANDALONE HOSPITALS SEGMENT IS PROJECTED TO BE THE FASTEST-GROWING END-USER SEGMENT IN CHINA (2015–2020)
Figure 32 LEADING MARKET PLAYERS ADOPTED PIPELINE DEVELOPMENT & PRODUCT ENHANCEMENT AS THEIR KEY GROWTH STRATEGY DURING 2012 TO 2015
Figure 33 GLOBAL PLATELET AGGREGATION DEVICES MARKET SHARE, BY KEY PLAYER, 2014
Figure 34 CONTINUOUS PRODUCT DEVELOPMENT & COMMERCIALIZATION IS STIMULATING MARKET COMPETITION AMONG KEY PLAYERS
Figure 35 GEOGRAPHIC REVENUE MIX OF THE TOP FOUR PLAYERS (2014)
Figure 36 STRATEGIC BENCHMARKING: LEADING COMPANIES FOCUS ON PRODUCT COMMERCIALIZATION TO STRENGTHEN THEIR MARKET POSITION
Figure 37 F. HOFFMAN-LA ROCHE LTD.: COMPANY SNAPSHOT
Figure 38 HAEMONETICS CORPORATION: COMPANY SNAPSHOT
Figure 39 SYSMEX CORPORATION: COMPANY SNAPSHOT
Figure 40 SIEMENS AG: COMPANY SNAPSHOT
